Building from a solid foundation based on direct factor VIII replacement, management of hemophilia A now includes nonfactor therapies. Here’s my take on progress and future directions.
Get an expert’s thoughts on key data most likely to affect care of patients with hemophilia presented at ASH 2020.
Read a discussion with 3 experts answering audience questions following 2 live Webcasts on contemporary management of hemophilia A.
Download this slideset to learn more about up-to-date management strategies to optimize outcomes for patients with hemophilia A.
Learn more about strategies to mitigate complications associated with factor replacement therapy and overcoming barriers to effective therapy
Learn about the latest data on nonfactor replacement therapies and their evolving role in the management of hemophilia A in by downloading this slideset.
Download this summary slideset of key takeaways from a CCO Live Webinar for expert insight on contemporary best practice management of hemophilia A, including prophylaxis, improving adherence, and emerging strategies to improve patient outcomes.
Learn about contemporary management of hemophilia A from a panel of experts in this on-demand Webcast from a live Webinar.
With updates from ASH 2020, current management of hemophilia A is discussed by a panel of experts in this on-demand Webcast from a live Webinar.
In this podcast episode, listen to Michael Callaghan, MD; Miguel A. Escobar, MD; and Rebecca Kruse-Jarres, MD, MPH, as they answer questions from a clinician audience on new and established approaches for managing hemophilia A in pediatric and adult patients.